Merck KGaA (FRA: MRK)

Market Cap	60.09B
Revenue (ttm)	20.96B
Net Income (ttm)	2.70B
Shares Out	n/a
EPS (ttm)	6.19
PE Ratio	22.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	580
Open	137.70
Previous Close	138.40
Day's Range	136.65 - 137.95
52-Week Range	136.65 - 176.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 6, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 62,908
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MRK

Financial Performance

In 2023, Merck KGaA's revenue was 20.99 billion, a decrease of -5.57% compared to the previous year's 22.23 billion. Earnings were 2.82 billion, a decrease of -15.09%.